Coverage Evaluation Survey for the Implementation of Mass Drugs Administration

On Behalf of World Health Organization - Indonesia

The World Health Organization (WHO) invites you to submit an Expression of Interest (EOI) for Coverage Evaluation Survey for the Implementation of Mass Drugs Administration with Alternative PC Regimen (Ivermectin, Diethylcarbamazine, and Albendazole) in Mamuju, Manowari Selatan, Kaimana, Biak Numfor, and Kota Sorong Districts which address the following objectives:

a. To estimate PC coverage – to obtain a precise estimate of PC coverage that can be compared with the target coverage threshold to determine if the MDA was effective.
b. To validate reported coverage – to check the accuracy of the data recording and reporting system and take corrective actions where necessary.
c. To identify reasons for non-compliance – by identifying common reasons for not swallowing the drugs, programme managers can improve social mobilization prior to the next MDA round.
d. To detect problems with the supply chain and distribution systems – can identify clusters of individuals for whom the drugs were never offered and corrective action can be taken.
e. To measure coverage in specific population: subpopulations, e.g.. Rural vs. urban.
 

Registration Procedure

If you are interested to join the solicitation, please register on the UNGM site by clicking here: https://www.ungm.org/ (Please ensure that you are registered as a company/institution, and not as an individual or consultant).

Note: UNGM registration is not a pre-approved vendor roster. Only invited bidders shall participate in tenders issued by WHO-SEARO. If you require assistance during the registration, please contact registry@ungm.org

Contact Address for EOI Response: seinobids@who.int